Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)

NCT01553032 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

139

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Erbitux®
RADIATION: Fractionated Radiotherapy

Sponsor

University of Heidelberg Medical Center

Collaborators

[object Object]